Contribution of tumour necrosis factor-alpha (TNF-α) in host defence mechanism against Cryptococcus neoformans

Clinical and Experimental Immunology

Volumn 106, Issue 3, 1996, Pages 468-474

  Kawakami, K ^a   Qifeng, X ^a   Tohyama, M ^a   Qureshi, M H ^a   Saito, A ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Cryptococcus neoformans; IL 12; Macrophages; Tumour necrosis factor alpha

Indexed keywords

INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCLONAL ANTIBODY; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HOST RESISTANCE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029851033     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-870.x     Document Type: Article

References (45)

1. Beutler B, Cerami A. The biology of cachectin/TNF: a primary mediator of the host response. Ann Rev Immunol 1989; 7:625 55.
2. Bauss F, Droge W, Mannel DN. Tumor necrosis factor mediates endotoxic effects in mice. Infect Immun 1987; 55:1622 5.
3. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin, Science 1985: 229:869-71.
4. Tracey KJ, Fong Y, Hesse DG, Manpgue KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662 4.
5. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antogonists. J Immunol 1993; 151:1548-61.
6. Nacy CA, Meierovics AI, Belosevic M, Green SJ. Tumor necrosis factor-α: central regulatory cytokine in the induction of macrophage antimicrobial activities. Pathology 1991; 59:182-7.
7. Harvell EA. Production of tumor necrosis factor during murine listeriosis. J Immunol 1987; 139:4225-31.
8. Nakano Y, Onozuka K, Terada Y, Shinomiya H, Nakano M. Protective effect of recombinant tumor necrosis factor-α in murine salmonelosis. J Immunol 1990; 144:1935 41.
9. Blanchard DK, Djeu JY, Klein TW, Friedman H, Stewart WE II. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukocyte Biol 1988; 43:429 35.
10. Denis M. Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J Leukocyte Biol 1991; 50:495-501.
11. Titus RG, Sherry B, Cerami A. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 1989; 170:2097-34.
12. Steinshamn S, Waage A. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun 1992; 60:4003-8.
13. 2-generating system of human neutrophils independently of the hydrolysis of phosphoinositides and the release of arachidonic acid. Biochem Biophys Res Commun 1990; 166:308-15.
14. Nathan CF. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6:3051 64.
15. Hunter CA, Subauste CS, Van Cleave VH, Remington JS. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 1994; 62:2818-24.
16. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol 1995; 13:251-76.
17. Hsieh C, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Listeria-induccd Th1 development in αβ-TCR transgenic CD4 T cells occurs through macrophage production of IL-12. Science 1993; 260:547-9.
18. Mosmann TR, Coffman RL. ThI and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7:145 73.
19. + T lymphocytes. In: Rich RR, Fleisher TA, Schwanz BD, Shearer WT, Strober W, eds. Clinical immunology: principles and practice. St Louis: Mosby-Year Book Inc., 1996:264 75.
20. Stevens DA. Fungal infections in AIDS patients. Br J Clin Practice 1990; 44 (Suppl. 1):11-22.
21. Gadebusch HH. Mechanisms of native and acquired resistance to infection with Cryptococcus neoformans. In: Laskin A, Lechevalier H, eds. Macrophages and cellular immunity. Boca Raton: CRC Press, 1972:3-28.
22. Kawakami K, Tohyama M, Teruya K, Kudeken N, Xie Q, Saito A. Contribution of Interferon-γ in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol Med Microbiol 1996; 13:123 30.
23. Salkowski CA, Balish E. A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic cryptococcosis. Infect Immun 1991; 59:486 93.
24. Tohyama M, Kawakami K, Futenma, M, Saito A. Enhancing effect of oxygen radical scavengers on anticryptococcal activity of murine peritoneal macrophages through production of nitric oxide. Clin Exp Immunol 1996; 103:436 41.
25. Kawakami K, Tohyama M, Xie Q, Saito A. Interleukin-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 1996; 104:208 14.
26. Brummer E, Stevens D. Anticryptococcal activity of macrophages: role of mouse strain. C5, contact, and L-arginine. Cell Immunol 1994; 157:1-10.
27. Yamada M, Furutani Y, Notake M et al. Efficient production of human tumor necrosis factor in Escherichia coli. J Biotechnol 1985 3:141 53.
28. Abrams JS, Roncarolo MG, Yssel H, Anderson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992; 127:5-24.
29. Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chroloform extraction. Anal Biochem 1987; 162:156-9.
30. Murray LJ, Lee R, Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL Mp-lpr lpr mouse. Eur J Immunol 1990; 20:163-70.
31. Montgomery R, Dallman MJ. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol 1991; 147:554-60.
32. Futenma M, Kawakami K, Saito A. Production of tumor necrosis factor-α in granulocytopenic mice with pulmonary candidiasis and its modification with granulocyte colony-stimulating factor. Microbiol Immunol 1995; 39:411 7.
33. Kramer SM, Aggarwal BB, Eassalu TE, McCabe SM, Derrailolo BL, Figari IS, Palladino MA Jr. Characterization of in vitro and in vivo species preference of human and murine tumor necrosis factor. Cancer Res 1988; 48:920-6.
34. Bermudez LEM, Stevens P, Kolonoski P, Wu M, Young LS. Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-1 and tumor necrosis factor. J Immunol 1989; 143:2996 3000.
35. Nasuland PK, Miller WC, Granger DL. Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells. Infect Immun 1995; 63:1298-304.
36. Vecchiarelli A, Retini C, Pietrella D, Monari C, Tascini C, Beccari T, Kozel TR. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1β secretion from human monocytes. Infect Immun 1995; 63:2919-23.
37. Collins HL, Bancroft GJ. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol 1992; 22: 1447 54.
38. Cross CE, Bancroft GJ. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and β-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun 1995; 63:2604 11.
39. Burchett SK, Weaver WM, Westall JA, Larsen A, Kronheim S, Wilson CB. Regulation of tumor necrosis factor cachectin and IL-1 secretion in human mononuclear phagocytes. J Immunol 1988; 140: 3473-80.
40. Liew FY, Li Y, Millott S. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990; 145:4306 10.
41. Munos-Fernandez MA, Fernandez MA, Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 1992; 22:301 7.
42. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989; 10:370 5.
43. Springer TA. Adhesion receptors of the immune system, Nature 1990; 346:425 33.
44. Baggiolin M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines, Adv Immunol 1944; 55:97 179.
45. Yokota S, Geppert TD, Lipsky PE. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J Immunol 1988; 140:531 6.